Skin conditions (dermatitis, eczema, psoriasis) decisions — 2025

The Board dismissed the appeals for service connection for obstructive sleep apnea, left knee pain, patellofemoral syndrome, and recurrent dermatitis/eczema of the posterior neck and bilateral hands due to untimely Notice of Disagreement (NOD) filings.

The Board granted service connection for pseudofolliculitis barbae and headaches, but remanded the claims for left foot pes planus, plantar fasciitis, right ankle disability, and hypertension.

The Board granted service connection for alcohol use disorder as secondary to the Veteran's PTSD and denied a rating greater than 60 percent for eczema and herpes simplex. The effective date of October 4, 2023 was granted for the grant of service connection for PTSD.

The Board denied an initial compensable rating for pseudofolliculitis barbae with residual scarring, finding that the evidence did not support a higher rating.

The Board denied service connection for hypertension and residuals of a stroke, finding no evidence linking these conditions to the Veteran's active service. The claims for acne, erectile dysfunction, and sinusitis were remanded for further development.

The Board denied a higher disability rating for hypertension and a compensable rating for eczema prior to May 19, 2023. The claim for TDIU was remanded.

The Veteran withdrew his appeal seeking a higher rating for leishmaniasis and id reaction dermatitis, bilateral lower extremities.

The Board granted service connection for a skin condition, diagnosed as seborrheic dermatitis, due to exposure to toxins in the Persian Gulf War based on medical evidence showing that seborrheic dermatitis was twice as common as expected in Gulf veterans.

The Board denied the Veteran's claim for an initial compensable rating for myeloma skin cancer, posterior trunk scar and remanded the issue of entitlement to an initial compensable rating for tinea versicolor disability.

The Board granted a 10 percent rating for impetigo and denied all other claims for increased ratings.

The Board denied all claims for increased ratings, finding that the evidence did not support a higher rating for any of the conditions.

The Board denied the veteran's claims for earlier effective dates for service connection and increased ratings, finding that the evidence did not support an earlier date than May 4, 2023.

The Board readjudicated the claims for service connection for bilateral hearing loss, a respiratory disability, and a skin disability based on new and relevant evidence. The claims for an acquired psychiatric disability, sleep impairment, hypertension, impaired vision, residual disability from vasectomy, and a compensable rating for scars were denied.

The Board remands the matter for further development, including obtaining a separation examination and an adequate medical opinion from a dermatologist or doctor.

The Veteran's attorney is not eligible for direct payment of attorney fees based on past-due benefits awarded in the November 2024 rating decision.

The Board dismissed the Veteran's claims for service connection and increased ratings due to improper concurrent election of multiple review options.

The Veteran's service-connected migraine headaches, along with other disabilities, have prevented her from obtaining and maintaining substantial and gainful employment, warranting an award of extraschedular TDIU and special monthly compensation at the housebound rate effective February 17, 2022.

The Board denied service connection for migraine headaches and a skin disability, to include dermatitis and psoriasis, as the evidence did not support a nexus between these conditions and the Veteran's military service.

The Board denied service connection for a skin disorder other than chloracne, to include as due to herbicide agent exposure.

The Board granted a 60 percent rating for bilateral lichen simplex/chronic dermatitis from February 19, 2015, to September 21, 2023.